20.10.2022

Deal |

2022

Hoxton Farms raises £20m for cultivated fat pilot facility

Founded: 2020

Investment Raised: GBP 20M €

Valuation Remains Undisclosed

Investors: AgFunder (https://agfunder.com/) BACKED VC (https://www.backed.vc/) Collaborative Fund (https://collabfund.com/) CPT Capital (https://cptcap.com/) Fine Structure Venture (https://finestructure.vc/) Founders Fund (https://foundersfund.com/) My Climate Journey Collective (https://www.mcjcollective.com/) Presight Capital (https://presight.vc/) Sustainable Food Ventures (https://www.sustainablefoodventures.com/) Systemiq Capital (https://www.systemiqcapital.earth/)

19.10.2022

Deal |

2022

Startup using machine learning to find new medicines Nucleome Therapeutics raises £38m

Founded: 2019

Investment Raised: GBP 38M €

Valuation Remains Undisclosed

Investors: British Patient Capital (https://www.britishpatientcapital.co.uk/) Johnson & Johnson Innovation (https://jnjinnovation.com/home) M Ventures (https://www.m-ventures.com/en) Oxford Science Enterprises (https://oxfordscienceenterprises.com/) Pfizer Venture Investments (https://www.pfizer.com/about/partners/venture-investments)

19.10.2022

Deal |

2022

Univercells Raises € 44 Million in First Close of Its Series D

Founded: 2013

Investment Raised: EUR 44M €

Valuation Remains Undisclosed

Investors: 3d investors (https://www.3d-investors.be/en) AdBio partners (https://adbio.partners/) Adjuvant Capital (https://adjuvantcapital.com/) Amerigo Fund (https://www.amerigocap.com/) Global Health Investment Corporation (https://ghicfunds.org/) S.R.I.W. (https://www.sriw.be/fr/) SFPI-FPIM (https://www.sfpi-fpim.be/en) TheClubDeal (https://theclubdeal.com/)

19.10.2022

Deal |

2022

Using “deep physics powered- AI”, Aqemia raises €30 million to further its drug discovery pipeline

Founded: 2019

Investment Raised: EUR 30M €

Valuation Remains Undisclosed

Investors: Bpifrance (https://www.bpifrance.com/) Elaia (https://www.elaia.com/) Eurazeo (https://www.eurazeo.com/en)

19.10.2022

Deal |

2022

Germany-based anvajo raises €17.7M for its point-of-care fluid analysis tool

Founded: 2016

Investment Raised: EUR 17.7M €

Valuation Remains Undisclosed

Investors: Die Brückenköpfe (https://brueckenkoepfe.de/) Johnsonville Ventures (https://w.pitchbook.com/profiles/investor/503409-43) Medice Arzneimittel (https://medice.com/de-de) Think.Health (https://think-health.de/)

18.10.2022

Deal |

2022

Anokion Announces $35 Million Equity Investment from Pfizer

Founded: 2010

Investment Raised: USD 35M €

Valuation Remains Undisclosed

Investors: Pfizer Breakthrough Growth Initiative (https://www.pfizer.com/)

17.10.2022

Deal of the Week |

Calendar Week # 43 |

2022

Neoplants has raised more than $20 million in funding

Founded: 2018

Investment Raised: USD 20M €

Valuation Remains Undisclosed

Investors: Collaborative Fund (https://collabfund.com/) Entrepreneur First (https://www.joinef.com/) Heartcore Capital (https://www.heartcore.com/) Niklas Zennström True Ventures (https://trueventures.com/)

28.09.2022

Deal |

2022

Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors

Founded: 2022

Investment Raised: USD 68M €

Valuation Remains Undisclosed

Investors: Atlas Venture (https://atlasventure.com/) Brandon Capital Partners (https://brandoncapital.vc/) Forbion Capital Partners (https://forbion.com/en/) Research Corporation Technologies (https://rctech.com/)

26.09.2022

Deal |

2022

German Cannabis company Sanity Group announces $37.6 Million Series B funding round

Founded: 2018

Investment Raised: USD 37.6M €

Valuation Remains Undisclosed

Investors: British American Tobacco (https://www.bat.com/) Casa Verde Capital (https://casaverdecapital.com/) Redalpine (https://redalpine.com/)

15.09.2022

Deal |

2022

Tridek-One brings in €16M to develop auto-immune diseases candidates

Founded: 2018

Investment Raised: EUR 16M €

Valuation Remains Undisclosed

Investors: AdBio partners (https://adbio.partners/) Advent Life Sciences (https://www.adventls.com/) Bioqube Ventures (https://www.bioqubeventures.com/) Bpifrance (https://www.bpifrance.com/) Pureos Bioventures (https://www.pureosbio.com/)

14.09.2022

Deal |

2022

Jeito Capital co-leads €75 million Series B financing in SparingVision

Founded: 2016

Investment Raised: EUR 75M €

Valuation Remains Undisclosed

Investors: 4BIO Capital (https://www.4biocapital.com/) Bpifrance (https://www.bpifrance.com/) Jeito Capital (https://www.jeito.life/en/home/) Retinal Degeneration Fund (https://www.retinaldegenerationfund.org/) UPMC Enterprises (https://enterprises.upmc.com/) Ysios Capital (https://ysioscapital.com/)

13.07.2022

Deal |

2022

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million

Founded: 2017

Investment Raised: USD 40.5M €

Valuation Remains Undisclosed

Investors: Asabys Partners (https://asabys.com/) Pfizer Breakthrough Growth Initiative (https://www.crunchbase.com/organization/pfizer-breakthrough-growth-initiative) Walleye Capital (https://walleyecapital.com/)

06.07.2022

Deal |

2022

Cambridge-based Nuclera is making biology accessible via desktop bioprinting, wraps up Series B at $58 million

Founded: 2013

Investment Raised: USD 58M €

Valuation Remains Undisclosed

Investors: Jonathan Milner Verve Ventures (https://www.verve.vc/)

05.07.2022

Deal |

2022

OQC rakes in $46 million to put quantum computers at the fingertips of businesses

Founded: 2017

Investment Raised: USD 46M €

Valuation Remains Undisclosed

Investors: British Patient Capital (https://www.britishpatientcapital.co.uk/) Lansdowne Partners (https://www.lansdownepartners.com/london/) Oxford Investment Consultants LLP (https://www.oxfordinvestmentconsultants.com/) Oxford Science Enterprises (https://oxfordscienceenterprises.com/) UTEC – The University of Tokyo Edge Capital Partners (https://www.ut-ec.co.jp/english/link)

30.06.2022

Deal |

2022

Ermium Therapeutics Extends Its Initial €6,3 M Funding to €12,3 M to Further Advance Breakthrough Auto-Immune Disease Therapeutics

Founded: 2019

Investment Raised: EUR 6M €

Valuation Remains Undisclosed

Investors: Fountain Healthcare Partners (https://www.fh-partners.com/) Kurma Partners (https://www.kurmapartners.com/en)

29.06.2022

Deal |

2022

MiroBio raises $97 million in Series B financing

Founded: 2019

Investment Raised: USD 97M €

Valuation Remains Undisclosed

Investors: Advent Life Sciences (https://www.adventls.com/) Medicxi (https://www.medicxi.com/) Monograph Capital (https://monograph.bio/) OrbiMed (https://www.orbimed.com/) Oxford Sciences Innovation (https://oxfordscienceenterprises.com/) Samsara BioCapital (https://www.samsaracap.com/) SR One (https://www.srone.com/)

22.06.2022

Deal |

2022

Meet Bio-Sep, the green tech is turning sawdust into valuable biochemicals with $1.7 million

Founded: 2010

Investment Raised: USD 1.7M €

Valuation Remains Undisclosed

Investors: ACF Investors (https://www.acfinvestors.com/) Enterprise 100 (https://enterprise100.co.uk/)

20.06.2022

Deal of the Week |

Calendar Week # 26 |

2022

MiroBio raises $97 million in Series B financing

Founded: 2019

Investment Raised: USD 97M €

Valuation Remains Undisclosed

Investors: Advent Life Sciences (https://www.adventls.com/) Medicxi (https://www.medicxi.com/) Monograph Capital (https://monograph.bio/) OrbiMed (https://www.orbimed.com/) Oxford Sciences Innovation (https://oxfordscienceenterprises.com/) Samsara BioCapital (https://www.samsaracap.com/) SR One (https://www.srone.com/)

07.06.2022

Deal |

2022

ImmunOs Therapeutics raises CHF 71 million in B round

Founded: 2014

Investment Raised: CHF 71M €

Valuation Remains Undisclosed

Investors: BioMedPartners (https://biomedvc.com/en/) Fiscus Financial (https://www.crunchbase.com/organization/fiscus-financial) Gimv (https://www.gimv.com/de) GL Capital (https://www.gl-investment.com/) Lightspeed Venture Partners (https://lsvp.com/) Mission BioCapital (https://www.missionbiocapital.com/) PEAK6 Investments LLC (https://peak6.com/) Pfizer Venture Investments (https://www.pfizer.com/about/partners/venture-investments) Samsara BioCapital (https://www.samsaracap.com/) Schroder Adveq (https://www.schroderscapital.com/en/site/home/)

31.05.2022

Deal |

2022

Minoryx announced a €51m C round led by Columbus Venture Partners and Caixa Capital Risc.

Founded: 2011

Investment Raised: EUR 51M €

Valuation Remains Undisclosed

Investors: Caixa Capital Risc (https://www.caixacapitalrisc.es/en/) Centre for the Development of Industrial Technology (CDTI) (https://www.cdti.es/index.asp?idioma=2&MS=193&MN=3&IDR=2535) Columbus Venture Partners Fund+ (https://fundplus.be/) Ysios Capital (https://ysioscapital.com/)

26.05.2022

Deal |

2022

Bringing nature data to the boardroom, NatureMetrics nets over €14 million

Founded: 2014

Investment Raised: EUR 14M €

Valuation Remains Undisclosed

Investors: 2150 (https://www.2150.vc/) Ananda Impact Ventures (https://ananda.vc/) Blue Oceans Partners (https://www.blueoceanspartners.com/) BNP Paribas (https://www.bnpparibas.at/en/) SYSTEMIQ (https://www.systemiq.earth/)

20.05.2022

Deal |

2022

Trill Impact leads the 240 MSEK venture financing round in Cinclus Pharma

Founded: 2014

Investment Raised: SEK 240M €

Valuation Remains Undisclosed

Investors: EIR Ventures (https://eirventures.eu/) Fjärde AP-fonden (https://www.ap4.se/) Irrus Investments (https://www.irrusinvestments.com/) Linc AB (https://linc.se/) Trill Impact (https://www.trillimpact.com/)

10.05.2022

Deal |

2022

Domain Therapeutics revenue to raise €39M

Founded: 2001

Investment Raised: EUR 39M €

Valuation Remains Undisclosed

Investors: 3B Future Health Fund (https://3bfuturehealth.com/) adMare Bio Innovations (https://www.admarebio.com/) CTI Life Sciences Fund (https://www.ctisciences.com/) Omnes Capital (https://www.omnescapital.com/) Panacea Venture (http://www.panaceaventure.com/) Schroders Capital (https://www.schroders.com/) Seventure Partners (http://www.seventure.fr/en/) Theodorus III Turenne Capital (https://www.turennecapital.com/) Viva BioInnovator (https://www.vivabioinnovator.com/)

03.05.2022

Deal |

2022

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

Founded: 2012

Investment Raised: EUR 60M €

Valuation Remains Undisclosed

Investors: Andera Partners (https://www.anderapartners.com/en/) Bayern Kapital (https://bayernkapital.de/) BioMedPartners (https://biomedvc.com/en/) coparion (https://www.coparion.vc/) Evotec (https://www.evotec.com/en) Fund+ (https://fundplus.be/) High-Tech Grunderfonds (https://www.htgf.de/) OCCIDENT (https://www.occident.group/) Seventure Partners (http://www.seventure.fr/en/)

03.05.2022

Deal |

2022

Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics

Founded: 2021

Investment Raised: CHF 15.5M €

Valuation Remains Undisclosed

Investors: Novo Holdings (https://www.novoholdings.dk/) Pureos Bioventures (https://www.pureosbio.com/)

30.03.2022

Deal |

2022

VectivBio Announces Licensing Agreement and Loan Agreement in Japan, Providing Up to $117 Million to Boost Business with Key Catalysts

Founded: 2019

Investment Raised: USD 117M €

Valuation Remains Undisclosed

Investors: Kreos Capital (https://www.kreoscapital.com)

28.03.2022

Deal |

2022

Sano Genetics raises £8.4m to connect rare disease patients with medicine providers

Founded: 2017

Investment Raised: GBP 8.4M €

Valuation Remains Undisclosed

Investors: Episode 1 (https://episode1.com) Margaret Georgiadis MMC Ventures (https://mmc.vc) Paul Forster Paul Wicks Seedcamp (https://seedcamp.com)

22.03.2022

Deal |

2022

ITM Receives €33 million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals

Founded: 2004

Investment Raised: EUR 33M €

Valuation Remains Undisclosed

Investors: Indigenous Critical Infrastructure Fund Canada (https://www.sac-isc.gc.ca/eng/1628172767569/1628172789746) Portland Holdings (http://www.portlandholdings.com)

16.03.2022

Deal |

2022

Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals

Founded: 2014

Investment Raised: EUR 80M €

Valuation Remains Undisclosed

Investors: BioMedPartners (https://biomedvc.com/en/) Forbion Capital Partners (https://forbion.com/en/) Gimv (https://www.gimv.com/de) HealthCap (https://www.healthcap.eu/) INKEF Capital Jeito Capital (https://www.jeito.life/en/home/) Novo Holdings (https://www.novoholdings.dk/) Pontifax (https://www.pontifax.com/) V-Bio Ventures (https://v-bio.ventures/)

16.03.2022

Deal |

2022

Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer

Founded: 2018

Investment Raised: EUR 18.5M €

Valuation Remains Undisclosed

Investors: 2invest (https://www.2invest.com/) 3B Future Health Fund (https://3bfuturehealth.com/) Ace Ventures (https://www.aceventures.com/) Alef 6 CDP Venture Capital (https://www.cdpventurecapital.it/cdp-venture-capital/) Claris Ventures (http://www.clarisventures.com/) Club degli Investitori (https://www.clubdeglinvestitori.it/it/) Ersel (https://www.ersel.it/tag/venture-capital) Italian Angels for Growth (https://www.italianangels.net/)